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different infective routes
Linlin Bao1†, Lili Xu1†, Hua Zhu1†, Wei Deng1, Ting Chen1, Qi Lv1, Fengdi Li1, Jing Yuan1, Yanfeng Xu1, Lan Huang1,
Yanhong Li1, Jiangning Liu1, Yanfeng Yao1, Pin Yu1, Honglin Chen2 and Chuan Qin1*Abstract
Background: On 19 February 2013, the first patient infected with a novel influenza A H7N9 virus from an avian
source showed symptoms of sickness. More than 349 laboratory-confirmed cases and 109 deaths have been reported
in mainland China since then. Laboratory-confirmed, human-to-human H7N9 virus transmission has not been
documented between individuals having close contact; however, this transmission route could not be excluded
for three families. To control the spread of the avian influenza H7N9 virus, we must better understand its
pathogenesis, transmissibility, and transmission routes in mammals. Studies have shown that this particular virus
is transmitted by aerosols among ferrets.
Methods: To study potential transmission routes in animals with direct or close contact to other animals, we
investigated these factors in a murine model.
Results: Viable H7N9 avian influenza virus was detected in the upper and lower respiratory tracts, intestine, and
brain of model mice. The virus was transmissible between mice in close contact, with a higher concentration of
virus found in pharyngeal and ocular secretions, and feces. All these biological materials were contagious for
naïve mice.
Conclusions: Our results suggest that the possible transmission routes for the H7N9 influenza virus were through
mucosal secretions and feces.
Keywords: H7N9 influenza virus, Direct contact, Route of transmission, Ocular secretions, Feces, Pharyngeal
secretionsBackground
On 19 February 2013, the first patient infected with the
novel influenza A H7N9 virus from an avian source
showed signs of sickness. More than 347 laboratory-
confirmed cases have been reported in mainland China,
with 109 cases resulting in death. Most cases of H7N9 in-
fection have occurred in elderly men who had recently
been exposed to live poultry. Patients with laboratory-
confirmed H7N9 infections had an exposure history that
included direct contact with respiratory secretions or fecal* Correspondence: qinchuan@pumc.edu.cn
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unless otherwise stated.material. Exposure to live poultry is a case-fatality risk as-
sociated with influenza A H7N9 virus infection [1-6]. Live
bird markets are suspected of being the source of human
infections; shutting down live poultry markets resulted in
an immediate reduction in cases [7]. There is a precedent
for the human transmission of H7 influenza, with limited
person-to-person transmission observed in an H7N7 out-
break in the Netherlands in 2003 [8]. Three suspected
family clusters of cases were reported [9], indicating the
possibility of limited human-to-human transmission of
the H7N9 virus [10].
Previous studies have reported aerosol transmission of
the H7N9 virus among ferrets [11]. Other researchers
have used a mouse model to study contact-dependent
transmission of influenza A virus [12]. We evaluated the
transmission of the H7N9 virus in mice to provide insights
into potential human transmissibility.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Pathogenicity of influenza virus strains in mice
Mice were infected with influenza A/Anhui/1/2013 virus
(106.25–108.25 TCID50) to determine the LD50 and survival
of H7N9 in mice (Figure 1a). The LD50 values of the three
viruses we investigated were 107.5, 101, and 104.8 TCID50
for H7N9, H5N1, and H1N1, respectively. At a dose of
106 TCID50, mice infected with H5N1 or H1N1 virus died
during the observation period (Figure 1b). After inocula-
tion with the H7N9 virus at 106 TCID50, weight loss was
observed at 2 days post inoculation (dpi; Figure 1c); the
average weight loss at 7 dpi was greater than 30%. Mice
infected with the H7N9 virus at 106 TCID50 exhibited
weight loss from 2 dpi but recovered around 8 dpi.
Virus titers in the tissues of infected mice administered
106 TCID50 of virus were determined using MDCK cells.
Viable virus was detected in the lungs of mice infected
with any of the influenza viruses from 1–7 dpi (Additional
file 1: Table S2). Virus was transiently isolated from the
liver, kidneys, and intestines of H5N1- or H7N9-infected
mice, but not H1N1-infected mice (Table 1). The viru-
lence of the H7N9 virus was less than that of the H5N1
virus. Viable virus was detected in the brains of 33% (2/6)
of H7N9-infected mice at 2 dpi. The distribution of vi-
ruses in tissues was assessed using immunohistochemistry
incorporating a mouse monoclonal antibody against the
influenza HA nucleoprotein (1:200 dilution). Following
H7N9 infection viable antigens were primarily located
within epithelial cells of the bronchi and alveoli in the
lungs, epithelial cells of the intestine, renal tubules in
the kidney, and gliocytes in the brain (Figure 2a). H5N1
antigens were also detected in the brain parenchyma
(Figure 2a). Viral antigens were mainly detected in the
lungs of H1N1-infected mice (Figure 2a). Confluent inter-
stitial pneumonia, necrosis of epithelial cells of the bron-
chi and alveoli, inflammatory cell infiltration, congestion,
and fibrin exudation were observed at 3 and 5 dpi in lung
tissues (Figure 2b).(a)
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Figure 1 Avian influenza virus H7N9 (A/Anhui/1/2013) infects mice. (a
(108.25–106.25 TCID50) are shown. (b) Survival comparison of mice infected wit
infected with 106 TCID50 of H7N9 (A/Anhui/1/2013). Data are presented a
(n =10 per group).H7N9 influenza virus transmission in mice
We sought to determine whether mice infected with the
H7N9 influenza virus could transmit virus to naïve mice
in close contact. At 24 h post-inoculation (hpi), seven
H7N9-naïve mice were introduced into the same cage as
three intranasally infected mice (107 TCID50). We de-
tected virus in the lungs and intestines of the initially un-
infected mice that were placed in contact with mice
exposed to H7N9 or H1N1 virus. We were unable to de-
tect H5N1 in either tissue (Table 2).
All mice (6/7) exposed to the H7N9 virus exhibited
weight loss; the maximal loss observed in one mouse was
6% (Table 2). Around 43% (3/7) of mice exposed to the
virus became infected (Table 2). Viable virus was detected
in the brain of one mouse and in the nose of another
mouse (Table 2). Approximately 6/7 mice exposed to
H1N1 exhibited weight loss; the highest level of weight
loss approached 11% (Table 2). Of the mice exposed to
H1N1, 57% (4/7) became infected (Table 2). In the tissues
of the naïve mice that were co-housed with H7N9-
infected mice, viral antigens were primarily located in the
lung and intestine, similar to their localization in infected
mice (Figure 3a). However, virus titers in contact mice
were lower than those in the infected mice. Mild lesions
were observed in the tissues of naïve mice that were
placed in contact with infected mice after 3 days. A dilated
area of interstitial pneumonia and congestion were ob-
served in lungs 7 days after contact with infected mice
(Figure 3b). We detected antibodies against H7 viruses in
seven naïve mice 14 days after contact with infected mice;
we also detected H7N9 virus in 3/7 naïve mice (Table 2).
Secretions from mice infected with H7N9 influenza virus
To evaluate the infectious secretions of H7N9-infected
mice, we collected eye and pharyngeal secretions from
inoculated mice at 1, 2, and 3 dpi and inoculated them
intranasally into mice. Virus was detected in the lungs
and intestinal tissues of mice inoculated with the ES-210 12 14
A/07/09 (H1N1)
Z/406H/06 (H5N1)
nhui/1/2013 (H7N9)
ction
(c)
) LD50 of A/Anhui/1/2013 (H7N9). Representative results of three doses
h H5N1, H1N1, or H7N9 viruses. (c) Percentage initial weight loss in mice
s the average values from two independent experiments ± SD
Table 1 Virus titers in the tissues of infected mice
Virusa Days
post-infection
Virus titer (log10TCID50 ± SD)
Heart Liver Spleen Lung Kidney Intestine Brain Nose
A/CA/07/09 (H1N1) 5 NPd -b + 4.83 ± 1.7 - - - NP
A/SZ/406H/06 (H5N1) 5 NP 3.62 ± 1.1 1.62 ± 0.23 3.50 ± 1.92 1.17 ± 0.32 1.38 ± 0.27 2.17 ± 0.41 NP
A/Anhui/1/2013 (H7N9) 1 - - - 4.00 ± 1.20 - - - 3.50 ± 1.38
2 - 0.81 1.50 5.50 ± 1.90 2.00 - +c 2.50 ± 0.75
3 - 0.75 - 5.00 ± 1.85 - - 2.50 ± 0.75
5 - - - 6.00 ± 2.15 - 0.86 ± 0.13 - 3.50 ± 1.38
7 - - - 3.50 ± 1.77 - 0.75 - 2.00 ± 0.38
aMice were infected with influenza viruses at a dose of 106 TCID50.
bViable virus was not detected after three passages in MDCK cells.
cCyotpathic effects were observed but TCID50 values were less than 0.5.
dNP, Not performed.
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ES-1 or ES-3 inocula. Virus was detected in the lungs
and intestinal tissues of mice administered the TS-1
(throat swab), −2, or −3 inocula. Virus was detected in
the lungs and intestines of mice inoculated with feces
from H7N9-infected mice (Table 3).
Transmission route of H7N9 in mice
We tested different transmission routes in contact mice.
When using ES inocula, viable virus was detected in the
intestines at 2 days, and in both the lungs and intestines
at 4 days. Virus antigens were detected in the lungs,
stomach, and intestines. TS inoculum was injected into
the tail veins of the mice, and viable virus was detected
in the same tissues as for the ocular route of administra-
tion. Following virus transmission by the fecal-oral
route, virus was detected in the nasal passages, trachea,
intestines, and lungs; viral antigens were detected in the
lungs, stomach, and intestines (Table 4). At 5 dpi, viral
antigens were detected in mice infected via the oral
route, primarily within the epithelial cells of the lungs,
gastric mucosa, and intestinal mucosa, and in infiltrating
inflammatory cells of the small intestine (Figure 4). At
the same time point, we also observed limited interstitial
pneumonia and inflammatory cell infiltration, degener-
ation and necrosis of mucosal and gastric epithelial cells,
vacuolar degeneration of the epithelial cells of the villi,
and degeneration of the small intestine.
Discussion
A second wave of H7N9 viral infections in humans oc-
curred in 2014 across China, with over 50 deaths re-
corded in 1 month. The Chinese government enforced a
temporary closure of live poultry markets in affected
provinces, resulting in an immediate reduction in the
number of human cases. This provided further evidence
of the role live poultry markets play in the spread of the
virus, and clearly showed that closure of the marketswas an effective control strategy [7]. However, the trans-
mission routes of the H7N9 virus remained unknown,
therefore it was still considered a serious threat to hu-
man health worldwide [13].
The mouse is a typical model used to evaluate the
virulence of influenza viruses, and in its quantitation. It
has been reported that a murine model can be used to
study contact-dependent transmission of the influenza A
virus [12]. In the current study, H7N9 virus-infected
mice displayed symptoms of lethality, with pathological
changes seen in mice that came in contact with infected
mice. We conducted a study on the aerosol transmission
of H7N9 in ferrets [11], and used a murine model to
study other potential routes of transmission.
Our results indicated that the novel H7N9 virus could
efficiently replicate in mice without prior host adaptation.
We inoculated BALB/c mice intranasally with A/Anhui/1/
2013 to determine H7N9 virus replication, morbidity (as
measured by weight loss), and the LD50 in mice. The LD50
titers for the H7N9 virus were lower than those for H5N1
and H1N1 viruses. Mice inoculated with H7N9 virus
showed severe morbidity (30% weight loss), a value com-
parable to that seen for HPAI H5N1 and H1N1 virus
infections, which have a high pathogenicity phenotype
in this model. Our findings were similar to those re-
ported in previous studies [14]. The H7N9 virus was
detected in extra-respiratory intestines, liver, spleen,
kidneys, and brains of infected mice, with viral antigen
detected in the same tissues. Weight loss was used as a
measurable outcome and a marker of virulence follow-
ing virus infection in these mice [15-20]. In our study,
the duration of H7N9 virus infection in mice was about
12 days, a similar duration to that seen with human
H7N9 infections (4–11 days) [15,21-23]. Virus was de-
tected at higher titers in the lungs than in nasal samples
(Table 1). From our transmission experiments we found
that virus titers in the lungs of co-housed mice at 5 dpi
were higher than those at 7 dpi, with the proportion of
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Figure 2 Histopathology and immunohistochemistry (IHC) analysis of infected mice. (a) Distribution of H7N9, H5N1, and H1N1 viruses in
the tissues of infected mice as determined by IHC. Representative viral antigen distribution in tissues at 3 dpi is shown. Viral antigens are denoted
with solid arrows (400× magnification). (b) Hematoxylin and eosin stain (HE) staining of lung tissues from infected mice (100× magnification).
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with the H7N9-infected mice were similar to those for
H1N1-infected mice. It was previously reported that an
avian H7N9 virus effectively replicated in mice with
minimal symptoms and that the virus could be trans-
mitted in mice without any pathogenic effects observed
[24]. Our results indicate that the H7N9 virus could be
transmitted in mice, however weight loss and ruffled
coats were observed. The virus was detected at different
time points and in several tissues, although virus titer
was low.The transmission of H7N9 influenza virus in ferrets
has been shown to occur via aerosols and respiratory
droplets [11,14]. Our results show that the H7N9 influ-
enza virus can also be transmitted between mice via eye
secretions (Table 4). Virus in the lung tissues was de-
tected at 4 dpi following ocular administration of ES in-
ocula in mice.
Eye and pharynx secretions, and feces from infected
mice proved to be infectious via mucosal, intravenous,
and oral routes. Virus was present in lung and intestinal
samples (Table 3); at 3 and 7 dpi, mild dilatation of the
Table 2 Transmissibility of H7N9 influenza virus in mice put in contact with infected mice
Virus Virus titer (mean log10TCID50 ± SD)
Lung Kidney Intestine Brain Nose Infected
contact miceb
Weight loss
(%)c
Seroconvertedd
Days post-infection 5 7 5 and 7 5 7 5 5
A/SZ/406H/06 A/CA/07/09 - NPa -f - - NP 0 0 0
2.07 ± 0.16 1.47 ± 0.19 NP - - - + 8/14 11 4/7
A/Anhui/1/2013 1.26 ± 0.41 0.67 ± 0.01 - 1.34 ± 0.25 0.97 ± 0.01 +e + 7/14 6 3/7
aNP, Not performed.
bNumber of contact mice containing virus in the lung, brain, and nose at 5 and 7 days after co-housing.
cMaximum proportional weight loss.
dHI titers >40.
eCyotpathic effects were observed but TCID50 values were less than 0.5.
fViable virus was not detected after three passages in MDCK cells.
Bao et al. Virology Journal 2014, 11:185 Page 5 of 9
http://www.virologyj.com/content/11/1/185interstitial pulmonary vasculature was observed in the
lungs (Figure 3b). Pathological changes in the lungs were
milder in naïve mice than in the infected mice; this dif-
ference positively correlated with the amount of virus
detected in naïve mice.
Our results indicate that influenza virus can be detected
in secretions from the eyes, throat and feces. Virus titer
was higher in throat secretions than from eye secretions
or fecal samples. Secretions from H7N9-infected mice are
able to transmit virus by the ocular, oral, and blood-borneLung In
3 dpi 7 dpi
(a)
(b)
C
on
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Figure 3 H7N9 virus is transmissible among mice by direct contact. S
with 106 TCID50 of H7N9 virus. (a) IHC observations in tissues of mice exposed
following exposure to infected mice. Viral antigens are denoted with solid arr
the bronchi and small intestinal villi, and within infiltrating inflammatory cells
in contact with H7N9-infected mice (100× magnification). At 3 days after
pulmonary vasculature was observed in the lungs; congestion was observroutes. An understanding of viral pathogenesis and of the
several transmission routes of the virus would allow for
various interventions in animals to prevent a future hu-
man pandemic [25].
Conclusion
Viable virus was found in secretions from the eyes and
oral cavities of mice infected with the H7N9 influenza
virus. The H7N9 virus was transmitted to contact mice
by several routes, including the mucosal and fecal-oraltestine
Control
even naïve mice were placed in direct contact with three mice infected
to H7N9-infected mice. Viral antigen distribution in tissues at 5 days
ows (400× magnification). Viral antigens are within the epithelial cells of
of the small intestine. (b) HE staining of lung tissue from mice that came
coming into contact with infected mice, mild dilation of the interstitial
ed after 7 days.
Table 3 Viable virus in naïve mice inoculated with eye,
nasal, or fecal samples
Virus
sample type
Virus titer (mean log10TCID50 ± SD)
Lung Intestine Nose
ES-1 - - -
ES-2 1.17 ± 0.30 0.94 ± 0.62 -
ES-3 - - -
TS-1 1.20 ± 0.30 0.94 ± 0.62 -
TS-2 1.02 ± 0.65 0.86 -
TS-3 0.86 0.86 -
F 0.86 0.86 -
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transmission of the novel H7N9 influenza virus in
humans.Materials and methods
Viruses
Influenza virus A/Anhui/1/2013 was isolated from a pa-
tient with a laboratory-confirmed human A (H7N9) virus
infection. The patient was a 35-year-old woman who lived
in the Anhui Province of China. On day 6 after the onset
of illness, she developed acute respiratory distress syn-
drome, septic shock, and acute renal damage; the patient
died 13 days later [1]. A throat swab (TS) was collected
from the patient and propagated in the allantoic sac and
amniotic cavity of 9–11-day-old embryonic chicken eggs.
The propagated virus was then passaged once in Madin-
Darby canine kidney (MDCK) cells. A Q226L (H3 num-
bering) substitution at the 210-loop of the HA gene was
found in this virus. This site has been shown to change re-
ceptor binding from avians to humans, possibly increasing
the ability of the virus to be transmitted by airborne routes
[26]. In addition, the virus encoded PB2 627 K, which is
essential for efficient replication of avian influenza viruses
in mammals. The highly pathogenic avian influenza A
(H5N1) virus A/Shenzhen/406H/06 and 2009 pandemic A
(H1N1) virus A/California/07/2009 were also isolatedTable 4 Detection of viable virus following inoculation of naï
Route of administration Days Virus titer in tissue (TC
Nose Trachea Intest
Oral 3 - - -
5 2.13 2.71 1.80
Intravenous 3 - - 1.80
5 - - 1.80
Eye 3 - - 2.05
5 - - 1.80from two patients and propagated in embryonic chicken
eggs and MDCK cells. The A (A/Shenzhen/406H/06;
H5N1) and 2009 pandemic A (A/California/07/2009;
H1N1) viruses were obtained from the University of Hong
Kong. MDCK cells were maintained in Eagle’s minimal
essential medium (EMEM, Invitrogen) supplemented
with 10% fetal bovine serum (FBS), 100 IU/ml penicil-
lin, and 100 μg/ml streptomycin, and were incubated at
37°C/5% CO2.
H7N9 influenza virus in mice
Murine studies were performed in an animal biosafety
level 3 (ABSL3) facility using HEPA-filtered isolators. All
procedures in this study involving animals were reviewed
and approved by the Institutional Animal Care and Use
Committee of the Institute of Laboratory Animal Science,
Peking Union Medical College (ILAS-PC-2013-006).
The 50% mouse lethal dose (LD50) of the virus was de-
termined by intranasally inoculating five groups of mice
(n =10 mice per group) with 10-fold serial dilutions of
the virus in a volume of 50 μl. The LD50 was calculated
by the method of Reed and Muench [27]. The H5N1
A/Shenzhen/406H/06 and H1N1 A/CA/07/09 strains
were used as controls. Mice were infected with 106
TCID50 of H7N9, H1N1, or H5N1 virus to compare the
virulence of strains.
We anesthetized female 4-week-old mice using iso-
flurane, and then inoculated them intranasally with the
appropriate virus. Heart, liver, spleen, lungs, kidney, in-
testines, brain tissue specimens and turbinate samples
were collected from mice and placed into 10% (w/v)
phosphate-buffered saline (PBS) on 1, 2, 3, 5, and 7 dpi
(Additional file 2: Table S1). Viruses were titrated in
MDCK cells and virus titer was expressed as TCID50, as
per the Reed-Muench method. We euthanized six mice
for every virus at each time point. Additionally, three
mice were sacrificed for every virus at each time point,
with lungs, intestines, and brain tissues collected for
immunohistochemical and pathological analysis. The
remaining 10 mice in each group were observed daily
for weight loss and mortality until 14 dpi.ve mice via different routes
ID50 ± SD) Viral antigen distribution in tissues
ine Lung Lung Stomach Intestine
- - - -
3.57 ± 1.13 2/3 2/3 2/3
2.89 ± 0.78 2/3 2/3 2/3
- - 1/3 1/3
- - 1/3 1/3
1.80 1/3 1/3 1/3
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Figure 4 Transmission of influenza H7N9 virus among mice. Naïve mice were inoculated with throat secretions collected from infected mice.
At 5 dpi, viral antigens were found in epithelial cells of the lungs, gastric and intestinal mucosa, and in infiltrating inflammatory cells of the small
intestine (solid arrows; 400× magnification). At 5 dpi, limited interstitial pneumonia and inflammatory cell infiltration, degeneration and necrosis
of epithelial cells in the gastric mucosa, and vacuolar degeneration of epithelial cells in small intestine villi was seen (100× magnification).
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Three groups of mice were used in this study. For each
group, three 4-week-old BALB/c mice were infected, and
seven naïve mice were placed in direct contact with in-
fected mice (Additional file 2: Table S1). The three in-
fected mice were lightly anesthetized and inoculated
intranasally with 50 μl of 107 TCID50 virus in PBS as
previously described. At 24 hpi, all materials in the cage
were replaced and sterilized, and the seven naïve mice
(co-housed mice) were placed in the same cage. The
seven co-housed mice were observed daily, with detailed
recording of clinical signs and weight loss continuing
until 14 dpi. To monitor viral shedding, nasal washes
were collected from seven co-housed mice at 3, 5, and 7
dpi. One group of mice was used for each time point.
We dripped 50 μl of PBS into the nose of each mouse;
the liquid was then allowed to fall back into a collection
tube. This was repeated three times. The seven co-
housed mice were then euthanized at 3, 5, and 7 dpi.
The lungs, kidney, brain, and intestines were collected,
and immersed into 1 ml of PBS. Virus titers in the tis-
sues were determined using MDCK cells as previously
described [27]. The number of co-housed mice that be-
came infected was calculated by determining the virus
titer in the lungs, brain, and nose at 5 and 7 days after
co-housing. Pathological examination of the lungs and
intestines occurred on days 3 and 7. Sera were obtained
from co-housed mice on 14 dpi to confirm seroconver-
sion using hemagglutination inhibition (HI) assays with
0.5% chicken erythrocytes.Secretions from H7N9-infected mice
To collect eye secretions (ESs), a swab pre-wetted with
PBS was used to wipe the eyes of six mice (5–7 wipes) at
1, 2, and 3 dpi, and then placed into 1 ml of PBS. Throat
swabs (TSs) were collected from inoculated mice at 1, 2,
and 3 dpi, and transferred to 1 ml of PBS. The ESs and
TSs were vortexed and centrifuged (300 g, 10 min), and
the supernatants filtered. Five pellets of fecal (F) samples
from inoculated animals were collected at 5 dpi and
placed into 10% (w/v) PBS, vortexed, and centrifuged
(300 g, 10 min). Supernatants were then filtered. The li-
quid from the ES, TS, and F samples were used to intrana-
sally inoculate mice on days 1, 2, and 3, respectively. Six
inoculated mice were then euthanized at 4 dpi (Additional
file 2: Table S1). Tissues from the lungs, nasal cavity, and
intestines were collected in 1 ml of PBS. Viral titers in tis-
sues were determined using MDCK cells as previously
described.Transmission route of H7N9 in mice
Conjunctival secretions from H7N9-infected mice were
used to wipe the eyes of twelve naïve mice (Eye). Pharynx
secretions were injected into the tail veins (150 μl per
mouse) of naïve mice (IV). The secretion was concen-
trated using a hyperfiltration tube (Millipore Amicon).
The virus titer of conjunctival secretions was 103.8
TCID50, while that for pharynx secretions was 10
3.8
TCID50. Similar virus titers were seen for the fecal sus-
pensions. Six naïve mice were given the fecal suspensions
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per mouse). Six mice infected through Or, Eye and IV
routes were autopsied at 3 and 5 dpi. Three mice were
used for the isolation of lung, tracheal, and intestinal
tissues for pathological and histochemical examinations
at 5 dpi. Three mice were used to obtain nasal washes
and lung tissues to determine virus titers at 3 and 5 dpi
(Additional file 2: Table S1).Virus titrations
Virus titrations were performed by end-point titration in
MDCK cells. MDCK cells were inoculated with 100.5-fold
serial dilutions of homogenized tissues, nasal washes, and
TSs. At 1 hpi, cells were washed once with PBS and incu-
bated in 200 μl of infection medium (EMEM, 100 U/ml
penicillin, 100 μg/ml streptomycin, and 1 μg/ml TPCK-
trypsin). At 3 dpi, supernatants of infected cell cultures
were tested for agglutinating activity using turkey erythro-
cytes as an indicator of cellular infection. Infectious titers
were calculated from five replicates using the Reed-
Muench method [27].Histopathology and immunohistochemistry (IHC)
Animal necropsies were performed according to stand-
ard protocols. Samples for histological examination,
comprising formalin-inflated lungs, were stored in
10% neutral-buffered formalin, embedded in paraffin, and
sectioned (4-μm thickness). The sections were stained
with hematoxylin and eosin (HE) for examination by light
microscopy, or via an immunohistochemical method
using a monoclonal antibody against the nucleoprotein of
influenza A virus. All slides were examined by a patholo-
gist with 10 years’ experience, and results were confirmed
by a second pathologist.HI assays
Standard HI assays were performed on post-exposure
mouse sera using 0.5% turkey erythrocytes against hom-
ologous virus. Sera were collected from inoculated or
naïve mice at 14 dpi or 14 days after coming into con-
tact with infected mice, respectively, and tested for the
presence of H7N9-specific antibodies.Statistical analysis
Differences in body weight, viral copy numbers, and
virus titers among groups were analyzed by one-way
ANOVA and post-hoc Bonferroni correction. Differences
between two groups were analyzed by Student’s t-test
using SPSS 11.5. A P-value less than 0.05 was considered
statistically significant.Additional files
Additional file 1: Table S2. Virus titers in the lungs of infected mice.
NP, Not performed. bDays post-infection. cMice were infected with viruses
at a dose of 106 TCID50.
Additional file 2: Table S1. Experimental mouse groups used in this
study.
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